4.3 Review

Pharmacological Profile of Quinoxalinone

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

Synthesis and antimicrobial activity of 2,3-bis(bromomethyl)quinoxaline derivatives

Hisato Ishikawa et al.

BIOORGANIC CHEMISTRY (2012)

Article Chemistry, Medicinal

A Potent and Selective Quinoxalinone-Based STK33 Inhibitor Does Not Show Synthetic Lethality in KRAS-Dependent Cells

Michel Weiwer et al.

ACS MEDICINAL CHEMISTRY LETTERS (2012)

Article Chemistry, Medicinal

Imidazo[1,5-a]quinoxalines as irreversible BTK inhibitors for the treatment of rheumatoid arthritis

Kyung-Hee Kim et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)

Article Chemistry, Medicinal

A novel potential therapeutic avenue for autism: Design, synthesis and pharmacophore generation of SSRIs with dual action

Ola M. Ghoneim et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)

Article Chemistry, Medicinal

Part I: Synthesis, cancer chemopreventive activity and molecular docking study of novel quinoxaline derivatives

Shadia A. Galal et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2011)

Article Biochemistry & Molecular Biology

Microwave assisted synthesis and antimicrobial activity of 2-quinoxalinone-3-hydrazone derivatives

Olayinka O. Ajani et al.

BIOORGANIC & MEDICINAL CHEMISTRY (2010)

Article Medicine, Research & Experimental

Reversal effect of substituted 1,3-dimethyl-1H-quinoxalin-2-ones on multidrug resistance in adriamycin-resistant K562/A02 cells

Li-rui Sun et al.

BIOMEDICINE & PHARMACOTHERAPY (2009)

Article Biochemistry & Molecular Biology

Synthesis and biological evaluation of N-4-(hetero) arylsulfonylquinoxalinones as HIV-1 reverse transcriptase inhibitors

Bailing Xu et al.

BIOORGANIC & MEDICINAL CHEMISTRY (2009)

Article Chemistry, Medicinal

Synthesis and SAR of novel tricyclic quinoxalinone inhibitors of poly(ADP-ribose)polymerase-1 (PARP-1)

Julie Miyashiro et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)

Article Chemistry, Medicinal

Synthesis and in vitro antitumor activity of new quinoxaline derivatives

Paola Corona et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2009)

Article Chemistry, Medicinal

Synthesis and primary evaluation of quinoxalinone derivatives as potent modulators of multidrug resistance

Hongyu Yuan et al.

MEDICINAL CHEMISTRY RESEARCH (2009)

Article Chemistry, Medicinal

Synthesis of new 2(1H)-quinoxalinone derivatives for antimicrobial and antiinflammatory evaluation

Osama I. El-Sabbagh et al.

MEDICINAL CHEMISTRY RESEARCH (2009)

Article Pharmacology & Pharmacy

Q39, a novel synthetic Quinoxaline 1,4-Di-N-oxide compound with anti-cancer activity in hypoxia

Qinjie Weng et al.

EUROPEAN JOURNAL OF PHARMACOLOGY (2008)

Article Chemistry, Medicinal

Synthesis of antimicrobial 2,9,10-trisubstituted-6-oxo-7,12-dihydro-chromeno[3,4-b]quinoxalines

Sandeep A. Kotharkar et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)

Article Chemistry, Medicinal

Synthesis and evaluation of 3-anilino-quinoxalinones as glycogen phosphorylase inhibitors

J Dudash et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2005)

Article Medicine, General & Internal

Methicillin-resistant staphylococcus aureus disease in three communities

SK Fridkin et al.

NEW ENGLAND JOURNAL OF MEDICINE (2005)

Article Chemistry, Medicinal

Heterocyclic thrombin inhibitors. part 2: Quinoxalinone derivatives as novel, potent antithrombotic agents

UJ Ries et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2003)

Review Biochemistry & Molecular Biology

Inhibitors of multidrug resistance to antitumor agents (MDR)

C Avendano et al.

CURRENT MEDICINAL CHEMISTRY (2002)

Article Chemistry, Medicinal

Structure-activity studies of substituted quinoxalinones as multiple-drug-resistance antagonists

DS Lawrence et al.

JOURNAL OF MEDICINAL CHEMISTRY (2001)

Article Chemistry, Medicinal

Synthesis and evaluation of quinoxalinones as HIV-1 reverse transcriptase inhibitors

M Patel et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2000)